SPRC Stock: Price, Forecast, Financials & AI Analysis

Loading...

Loading chart...

High

3.910

Open

3.910

VWAP

3.72

Vol

20.76K

Mkt Cap

2.27M

Low

3.611

Amount

77.24K

EV/EBITDA(TTM)

--

Total Shares

565.50K

EV

3.54M

EV/OCF(TTM)

--

P/S(TTM)

--

Scisparc Ltd, former Therapix Biosciences Ltd is a Israel-based pharmaceutical company commited into creating and enhancing technologies and assets based on cannabinoid pharmaceuticals. The company is engaged in drug development programs based on repurposing a cannabinoid (Dronabinol): THX-110 for the treatment of Tourette syndrome (TS), for the treatment of Obstructive Sleep Apnea (OSA), and the treatment of Pain; THX-130 for the treatment of Mild Cognitive Impairment (MCI) and Traumatic Brain Injury (TBI); THX-150 for the treatment of infectious diseases; and THX-160 for the treatment of pain.

Show More

Events Timeline

(ET)

2026-03-10

09:30:00

SciSparc's NeuroThera Acquires 54.01% Stake in CliniQ

2026-03-03 (ET)

2026-03-03

20:00:00

Scisparc Ltd Trading Halted, News Pending

2026-02-17 (ET)

2026-02-17

17:30:00

SciSparc Files to Sell 23.04M Ordinary Shares

2026-02-03 (ET)

2026-02-03

16:40:00

SciSparc Files $50M Mixed Securities Shelf

2026-01-26 (ET)

2026-01-26

08:20:00

SciSparc Completes Acquisition of Xylo's IP Portfolio

2026-01-13 (ET)

2026-01-13

07:10:00

SciSparc Acquires Patent Portfolio from Xylo Technologies

2026-01-12 (ET)

2026-01-12

16:10:00

SciSparc Notified by Nasdaq of Non-Compliance with Listing Requirements

2025-12-30 (ET)

2025-12-30

08:40:00

SciSparc's NeuroThera Labs Secures Patent from Israel

News

Newsfilter

03-10Newsfilter

SciSparc Acquires Controlling Interest in CliniQuantum

Yahoo Finance

03-10Yahoo Finance

Clearmind Unveils Patent for Innovative Weight Loss Therapy

NASDAQ.COM

01-16NASDAQ.COM

Sanofi Secures EU Approval for Teizeild, Demonstrating Significant Efficacy in Type 1 Diabetes

Benzinga

SciSparc Ltd. Acquires Endoscopy Patents, Shares Drop 12.07%

seekingalpha

01-13seekingalpha

SciSparc (SPRC) Faces Nasdaq Compliance Risk Due to Negative Equity

Globenewswire

2025-12-30Globenewswire

SciSparc Secures Israeli Patent Enhancing Opioid Efficacy

Valuation Metrics

The current forward P/E ratio for Scisparc Ltd (SPRC.O) is 0.00, compared to its 5-year average forward P/E of -11.36. For a more detailed relative valuation and DCF analysis to assess Scisparc Ltd's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

dotted line Image

N/A

5Y Average PE

-11.36

Current PE

0.00

Overvalued PE

26.06

Undervalued PE

-48.78

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

dotted line Image

N/A

5Y Average EV/EBITDA

0.00

Current EV/EBITDA

0.00

Overvalued EV/EBITDA

0.00

Undervalued EV/EBITDA

0.00

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

dotted line Image

N/A

5Y Average PS

1.42

Current PS

0.19

Overvalued PS

4.48

Undervalued PS

-1.63

Financials

AI Analysis

Annual

Quarterly

Related Community Screener

best swing trades for nest week under $25

Intellectia · 287 candidates

Price: <= $25.00Rsi Category: moderateRelative Vol: >= 1.50List Exchange: XNYS, XNAS, XASEMoving Average Relationship: PriceAboveMA20Week Price Change Pct: $3.00 - $25.00Macd: bullish, positive

Ticker

Name

Market Cap$

Allarity Therapeutics Inc

19.94M

Vivid Seats Inc

77.12M

Processa Pharmaceuticals Inc

6.46M

Smith Micro Software Inc

17.54M

Scisparc Ltd

3.14M

Bt Brands Inc

9.48M

Find stocks with low float

Intellectia · 2888 candidates

Region: USShares Outstanding: <= 150,000,000

Ticker

Name

Market Cap$

Aditxt Inc

2.59M

Greenwave Technology Solutions Inc

4.33M

Golden Heaven Group Holdings Ltd

5.19M

American Rebel Holdings Inc

3.47M

iPower Inc

5.62M

UTime Ltd

1.44M

3 stocks with RSI below 25

Intellectia · 221 candidates

Rsi Category: oversold

Ticker

Name

Market Cap$

Wix.Com Ltd

4.37B

Volato Group Inc

3.65M

Outlook Therapeutics Inc

32.44M

Jet.AI Inc

5.42M

Scisparc Ltd

4.57M

iPower Inc

5.62M

Whales Holding SPRC

Trading Trends

People Also Watch

Frequently Asked Questions

What is Scisparc Ltd (SPRC) stock price today?

The current price of SPRC is 3.64 USD — it has decreased -9.45

What is Scisparc Ltd (SPRC)'s business?

Scisparc Ltd, former Therapix Biosciences Ltd is a Israel-based pharmaceutical company commited into creating and enhancing technologies and assets based on cannabinoid pharmaceuticals. The company is engaged in drug development programs based on repurposing a cannabinoid (Dronabinol): THX-110 for the treatment of Tourette syndrome (TS), for the treatment of Obstructive Sleep Apnea (OSA), and the treatment of Pain; THX-130 for the treatment of Mild Cognitive Impairment (MCI) and Traumatic Brain Injury (TBI); THX-150 for the treatment of infectious diseases; and THX-160 for the treatment of pain.

What is the price predicton of SPRC Stock?

Wall Street analysts forecast SPRC stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for SPRC is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Scisparc Ltd (SPRC)'s revenue for the last quarter?

Scisparc Ltd revenue for the last quarter amounts to 78.09 USD, decreased

What is Scisparc Ltd (SPRC)'s earnings per share (EPS) for the last quarter?

Scisparc Ltd. EPS for the last quarter amounts to USD, decreased

How many employees does Scisparc Ltd (SPRC). have?

Scisparc Ltd (SPRC) has 2 emplpoyees as of March 11 2026.

What is Scisparc Ltd (SPRC) market cap?

Today SPRC has the market capitalization of 2.27M USD.